Platelets without donors, cheaper, faster, and better
We grow platelet lysates that perform just like traditional blood serum, offering unmatched consistency across cell culture applications.
How our platelet lysates can help you
-
Biomanufacturing
Donor-Free, Consistent Manufacturing
Our platelet lysates minimize batch-to-batch variation, enhancing drug development with a reliable, donor-free solution.
-
Platelet-Rich Plasma
Revolutionizing Skin and Hair Regeneration
Our human platelet lysates works universal and has been proven effective at growing stem cells, fibroblasts, and skin cells without the need for any blood serum.
-
Longevity
Life Extension with Platelet-Derived Extracellular Vesicles
Recent findings show that the rejuvenative effect of young plasma is driven by their extracellular vesicles, secretions of blood platelets. We developing methods to extract these vesicles for life extension purposes. -
Red Blood Cells
Cost-Effective, Plasma-Free Red Blood Cells
By eliminating plasma from the growth process, we're setting new standards for economical and sustainable production of red blood cells.
Meet Plasma Bioworks
We are Plasma Bioworks because we bioengineer plasma-grade ingredients for life science.
Our mission is end the life sciences' dependence on donor-derived plasma and blood products.
We want to create a future where platelets are no longer scarce, but abundant.
Our dream? To help people live longer, heal faster, and unlock the next era of regenerative medicine.
Highlights of Plasma Bioworks (née Wasna)
-
The Liveability Challenge 2022 Grand Finalist
9 June 2022
Following a 6-month journey and beating more than 400 other applicants from over 60 countries.
Plasma Bioworks was selected as a Grand Finalist for the Liveability Challenge 2022.
-
Plasma Bioworks featured in the South China Morning Post
19 January 2023
How Singapore’s deep-tech biomedical start-ups are growing rapidly – and helping to change the world.
-
The Slingshot 2022 Second Runner Up
30 October 2022
SLINGSHOT 2022 attracted applications from over 3,600 startups across more than 150 countries.
Plasma Bioworks was selected as the second runner up and awarded 140K USD of non-dilutive funding.